Qlife Holding AB (publ) (QLIFE.ST)
SEK 2.1
(5.53%)
SEK 2.1
(5.53%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -526.52 SEK | 69.91% |
| 2022 | -1749.88 SEK | -103.75% |
| 2021 | -858.83 SEK | -58.69% |
| 2020 | -541.19 SEK | 0.0% |
| 2019 | - SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -11.03 SEK | 57.36% |
| 2024 Q1 | -25.87 SEK | 88.0% |
| 2023 FY | - SEK | 69.91% |
| 2023 Q3 | -17.25 SEK | 71.83% |
| 2023 Q4 | -215.61 SEK | -1149.91% |
| 2023 Q1 | -233.18 SEK | 37.59% |
| 2023 Q2 | -61.23 SEK | 73.74% |
| 2022 Q3 | -428.14 SEK | -16.42% |
| 2022 Q2 | -367.77 SEK | -31.98% |
| 2022 Q1 | -278.65 SEK | 3.4% |
| 2022 FY | - SEK | -103.75% |
| 2022 Q4 | -373.62 SEK | 12.73% |
| 2021 Q1 | -169.63 SEK | 11.77% |
| 2021 FY | - SEK | -58.69% |
| 2021 Q4 | -288.45 SEK | -5.38% |
| 2021 Q3 | -273.73 SEK | -13.92% |
| 2021 Q2 | -240.29 SEK | -41.66% |
| 2020 FY | - SEK | 0.0% |
| 2020 Q4 | -192.26 SEK | -175.72% |
| 2020 Q3 | -69.73 SEK | -142.29% |
| 2020 Q2 | -28.78 SEK | 89.9% |
| 2020 Q1 | -284.85 SEK | 0.0% |
| 2019 Q3 | -101.48 SEK | -17.78% |
| 2019 FY | - SEK | 0.0% |
| 2019 Q1 | -62.07 SEK | 0.0% |
| 2019 Q2 | -86.16 SEK | -38.81% |
| 2019 Q4 | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acarix AB (publ) | -0.16 SEK | -328975.0% |
| ADDvise Group AB (publ) | 0.56 SEK | 94121.429% |
| ADDvise Group AB (publ) | 0.56 SEK | 94121.429% |
| Arcoma AB | 0.19 SEK | 277215.789% |
| Bactiguard Holding AB (publ) | -3.95 SEK | -13229.62% |
| BICO Group AB (publ) | -12.99 SEK | -3953.272% |
| Boule Diagnostics AB (publ) | 0.64 SEK | 82368.75% |
| CellaVision AB (publ) | 5.46 SEK | 9743.223% |
| Clinical Laserthermia Systems AB (publ) | -23.76 SEK | -2115.993% |
| Chordate Medical Holding AB (publ) | -0.13 SEK | -404915.385% |
| C-Rad AB (publ) | 1.05 SEK | 50244.762% |
| Duearity AB (publ) | -0.40 SEK | -131530.0% |
| Dignitana AB (publ) | -0.25 SEK | -210508.0% |
| Episurf Medical AB (publ) | -0.36 SEK | -146155.556% |
| Getinge AB (publ) | 8.86 SEK | 6042.664% |
| Scandinavian Real Heart AB (Publ) | -0.70 SEK | -75117.143% |
| Iconovo AB (publ) | -4.39 SEK | -11893.622% |
| Integrum AB (publ) | 0.23 SEK | 229021.739% |
| Luxbright AB (publ) | -0.37 SEK | -142202.703% |
| Mentice AB (publ) | -0.11 SEK | -478554.545% |
| OssDsign AB (publ) | -1.59 SEK | -33014.465% |
| Paxman AB (publ) | 0.44 SEK | 119763.636% |
| Promimic AB (publ) | -0.50 SEK | -105204.0% |
| SciBase Holding AB (publ) | -0.51 SEK | -103139.216% |
| ScandiDos AB (publ) | -0.32 SEK | -164437.5% |
| Sectra AB (publ) | 2.22 SEK | 23817.117% |
| Sedana Medical AB (publ) | -0.60 SEK | -87653.333% |
| Senzime AB (publ) | -1.45 SEK | -36211.724% |
| SpectraCure AB (publ) | -0.21 SEK | -250623.81% |
| Stille AB | 5.31 SEK | 10015.631% |
| Vitrolife AB (publ) | -28.44 SEK | -1751.336% |
| Xvivo Perfusion AB (publ) | 3.07 SEK | 17250.489% |